| Message: | (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone
MF: C20H18FNO4
MW: 355.36
Assay: 99%
Appearance:Off-White Solid
Package:1kg/drum
Standard: USP Standard
Usage:Ezetimibe intermediates
About Ezetimibe: Ezetimibe,jointly developed by Schering-Plough and Merck companies ,is the first selective cholesterol absorption inhibitor, the product is first approved by the US FDA listed as selective cholesterol absorption inhibitor class of drugs. Trade name is"EZETROL".
Ezetimibe is a new selective cholesterol absorption inhibitor, it is also the first selective inhibitor of intestinal cholesterol absorption, and its mechanism of action is different from other lipid-lowering agents (such as: statins, bile acid sequestrants, phenoxy acid derivative thereof cattle and plant sterol ester compound), the product ,through binding with the intestinal brush border membrane vesicle membrane protein (relative molecular mass 145X103), inhibits intestinal absorption of cholesterol which is from diet and transported to the intestine via the bile tract , reduces serum and liver cholesterol.
About our company:
Wuhan YC Technology Co., Ltd. is a high-tech enterprises in Hubei Province, which is professional engaged in fine chemicals, flavors and fragrances, food additives, pharmaceutical raw materials and intermediates products research, development, production, management, sales in one of the high-tech chemical enterprise. Our company has its own import and export rights, the products sell well all over the country and exported to Europe and the United States and Southeast Asia, more than and 20 countries and area, praised by customers
Contact:Felicity.Fu
Email:xly@ycphar.com
Skype:felicityfu209
|
my account
